Steris FY27 Q1 net income rises 13% to $200.1 million; revenue increases 7% to $1.5 billion

• Steris fiscal 2027 Q1 net income rose to $200.1 million; diluted EPS increased to $2.04.
• Revenue climbed 7% to $1.5 billion; adjusted net income rose to $253.4 million, lifting adjusted EPS to $2.59.
• Healthcare revenue rose 8% to $1.05 billion; operating income increased to $260.2 million, partly offset by inflation and tariff costs.
• Applied Sterilization Technologies revenue increased 6% to $297.6 million; operating income edged up to $142.9 million on improved price.
• Reiterated fiscal 2027 adjusted EPS outlook of $11.10-$11.30; raised capital spending to $450 million, cutting free cash flow view to $800 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Steris plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608051630PRIMZONEFULLFEED9804394) on August 05, 2026, and is solely responsible for the information contained therein.